ArticleInternational orthopaedics2016
Metabolic syndrome and shoulder arthroplasty: epidemiology and peri-operative outcomes.
Article in International orthopaedics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lack of level I evidence on how to prevent infection after elective shoulder surgery.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2018Pooled it
- Pulmonary embolism after shoulder surgery: Is it a real threat?World journal of methodology · 2025Review
- The Impact of Triglyceride-Glucose Index Levels During Perioperative Period on Outcomes in Femoral Neck Fracture Patients.Geriatric orthopaedic surgery & rehabilitation · 2024Article
- Components of metabolic syndrome as significant risk factors for postoperative complications following total shoulder arthroplasty: hypertension, diabetes, and obesity.JSES international · 2024Article
- The Effect of Diabetes and Metabolic Syndrome on Spine Surgery Outcomes.Current reviews in musculoskeletal medicine · 2023Review
- Biopsychosocial Approach in Identifying Risk Factors of Kinesiophobia in Persons with Subacromial Pain Syndrome and Developing a Clinical Prediction Tool.Indian journal of orthopaedics · 2023Article
- Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion.Medicine · 2020Observational
- Trends in total shoulder arthroplasty from 2005 to 2018: lower complications rates and shorter lengths of stay despite patients with more comorbidities.JSES international · 2020Article
- Risk of postoperative pulmonary complications in adult surgical patients with metabolic syndrome: a systematic review and meta-analysis protocol.Systematic reviews · 2019Article
- Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England.BMJ (Clinical research ed.) · 2019Article
- The impact of metabolic syndrome on 30-day outcomes in geriatric hip fracture surgeries.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLittle is known about metabolic syndrome in the peri-operative shoulder surgery setting. We sought to determine the prevalence of metabolic syndrome in patients undergoing shoulder arthroplasty, and to characterize its relationship with in-hospital adverse events, prolonged length of stay, and non-routine disposition.
methodsUsing discharge records from the 2002-2011 Nationwide Inpatient Sample, temporal trends were assessed and multivariable logistic regression modeling was used to measure the association of metabolic syndrome with peri-operative outcomes.
resultsThe prevalence of metabolic syndrome increased by 257 % from 2002 to 2011 (4.2 to 15.0 %). Metabolic syndrome was associated with increased aggregate morbidity (OR 1.34, 95 % CI 1.30-1.38), including acute renal failure (OR 1.51, 95 % CI 1.41-1.63), surgical site infection (OR 1.41, 95 % CI 1.16-1.71), myocardial infarction (OR 1.32, 95 % CI 1.12-1.55), acute posthemorrhagic anemia (OR 1.30, 95 % CI 1.26-1.34), and pulmonary embolism (OR 1.27, 95 % CI 1.06-1.52). It was also associated with prolonged hospital stay (OR 1.13, 95 % CI 1.10-1.16), non-homebound discharge (OR 1.29, 95 % CI 1.26-1.32), and increased blood transfusion use (OR 1.09, 95 % CI 1.06-1.13).
conclusionsMetabolic syndrome is increasing rapidly among shoulder arthroplasty patients and is associated with considerable peri-operative morbidity and resource utilization. Greater awareness of metabolic syndrome and its health consequences may contribute to improvements in the peri-operative management of shoulder arthroplasty patients.
Indexed as
Identifiers
27138608What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.